Professor Wu Liyong: Frontotemporal Dementia and Complex Cognitive Disorder Specialist
Professor Wu Liyong is a senior neurologist, professor, doctoral supervisor, and deputy director of the Department of Neurology at Xuanwu Hospital in Beijing. His clinical and academic work focuses on frontotemporal dementia, early-onset dementia, rapidly progressive cognitive decline, neurodegenerative disease, encephalitis, central nervous system infection, prion disease, and headache.
International patients can learn more about the hospital and neurological services in our Xuanwu Hospital international patient guide. Patients researching autoimmune neurological disease can also read our profile of Professor Hao Junwei.
Clinical and Academic Focus
- frontotemporal dementia;
- early-onset and atypical dementia;
- Alzheimer’s disease;
- rapidly progressive cognitive impairment;
- behavioral and language-led neurodegenerative syndromes;
- encephalitis and meningitis;
- prion disease;
- complex headache; and
- second opinions after uncertain cognitive diagnosis.
Frontotemporal Dementia
Frontotemporal dementia is a group of disorders affecting the frontal and temporal brain networks. It often begins before the typical age of Alzheimer’s disease and may first cause personality change, loss of judgment, apathy, compulsive behavior, altered eating, language difficulty, or problems with planning rather than memory loss.
Diagnosis may involve detailed history from family members, neurological and cognitive examination, brain MRI, PET imaging, neuropsychological testing, laboratory studies, and genetic counseling in selected families.
Professor Wu’s research has examined brain-network patterns underlying behavioral and language symptoms in frontotemporal dementia.
Early-Onset and Atypical Dementia
Cognitive decline beginning before age 65 requires careful evaluation because the range of possible causes is broad. These include Alzheimer’s disease, frontotemporal degeneration, Lewy body disease, vascular disease, inherited conditions, inflammatory disease, infection, metabolic disorders, medication effects, sleep disorders, and severe psychiatric illness.
Atypical Alzheimer’s disease may initially affect vision, language, movement, or executive function rather than presenting as classic memory loss.
Rapidly Progressive Cognitive Decline
Cognitive or behavioral decline developing over weeks or months is a neurological priority. Potential causes include autoimmune encephalitis, infection, seizures, cancer-related immune syndromes, toxic or metabolic disease, vascular disorders, and prion disease.
Evaluation can require urgent MRI, EEG, spinal-fluid testing, autoimmune and infection studies, and selected protein biomarkers. Some causes are treatable, so a rapidly progressive syndrome should not automatically be labeled dementia.
Prion Disease
Prion diseases are rare, rapidly progressive neurodegenerative disorders. Symptoms can include cognitive decline, imbalance, involuntary movements, visual problems, and changes in muscle tone.
Diagnosis relies on the clinical pattern together with MRI, EEG, spinal-fluid biomarkers, and exclusion of treatable mimics. Infection-control precautions may be required for certain procedures and tissue handling.
Encephalitis and Central Nervous System Infection
Encephalitis and meningitis can result from viruses, bacteria, fungi, parasites, tuberculosis, or immune-mediated disease. Symptoms can include fever, headache, neck stiffness, confusion, seizures, weakness, or reduced consciousness.
These conditions may require immediate local hospital treatment. International travel must not delay antimicrobial therapy, seizure control, or intensive care when a patient is acutely ill.
Headache
Professor Wu also evaluates primary and secondary headache. Sudden thunderclap headache, headache with fever or neurological deficit, new headache during pregnancy, or headache after trauma requires urgent assessment.
For chronic headache, diagnosis depends on symptom pattern, triggers, medication use, neurological examination, and selective imaging rather than imaging alone.
Who May Consider a Consultation?
- patients with suspected frontotemporal dementia;
- patients with cognitive decline before age 65;
- patients with personality or language change of uncertain cause;
- patients with rapidly progressive cognitive or behavioral decline;
- patients whose diagnosis alternates between dementia, psychiatric illness, infection, and autoimmune disease;
- patients with suspected prion disease;
- patients with complex encephalitis or meningitis recovery; or
- families seeking a second opinion and long-term care plan.
Medical Records to Prepare
- a detailed timeline of cognitive, behavioral, language, and functional change;
- brain MRI and PET imaging in original DICOM format;
- formal neuropsychological and cognitive testing;
- EEG recordings and reports;
- spinal-fluid results, including infection, autoimmune, and dementia or prion biomarkers;
- blood tests for metabolic, endocrine, infectious, and genetic causes;
- family history across at least three generations when possible;
- short examples of language, behavioral, or movement changes when appropriate;
- a complete medication list; and
- a clear list of diagnostic and care-planning questions.
Planning an International Consultation
Patients with rapidly declining consciousness, new seizures, fever with confusion, sudden weakness, or a severe abrupt headache require immediate local emergency care.
Stable patients should confirm whether imaging and test data can be reviewed. Remote medical-record review requires physician authorization. Final diagnosis may require in-person examination, repeat cognitive testing, spinal-fluid studies, or multidisciplinary assessment.
How CMCS Can Assist
CMCS – China Medical Concierge Shanghai is an independent medical concierge and health management company, not a hospital. We assist international patients and families with organizing and translating neurological records, identifying an appropriate specialist, requesting appointment availability, arranging interpretation, and planning medical travel in China.
Access to Professor Wu, remote review, admission, testing, or a particular treatment is subject to doctor and hospital approval. CMCS does not guarantee appointments, diagnosis, treatment eligibility, or clinical outcomes.
- Email: contract@medicalsh.com
- WhatsApp: Contact us on WhatsApp
- Website: www.medicalsh.com
Important Note
Doctor titles, clinical roles, testing, treatment availability, and appointment arrangements may change. This profile is based on the supplied verified research document and is for general information only. It does not replace assessment by a qualified neurologist.
0 commenti